COMPARATIVE OUTCOMES BETWEEN LETROZOLE PLUS MISOPROSTOL AND MIFEPRISTONE PLUS MISOPROSTOL IN TERMINATING NON-VIABLE FIRST TRIMESTER PREGNANCIES: A RANDOMISED CONTROL TRIAL IN A TERTIARY CENTER OF EASTERN INDIA

A single-centre open-label pragmatic randomised control trial in Calcutta National Medical College, a tertiary care centre in eastern India (Institutional Ethics Committee approval number : G & O/CNMC-118 dated 29.12.2021 and ClinicalTrials.gov ID number NCT05304273) from 5th May 2022 to 26th July 2024.